/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Differences in recommendations and associated level of evidence for statins in primary prevention of CVD according to the ACC/AHA 2013, CCS 2016, ESC 2016, and USPSTF 2016 clinical practice guidelines
Event: ESC Congress 2017
Topic: Epidemiology, lipids
Session: Prevention general
Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease using clinical trial evidence: results from the prospective population-based Rotterdam Study
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Lipid lowering therapy in primary cardiovascular prevention
ESC 365 is supported by
